tiprankstipranks
Trending News
More News >
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX
US Market

XORTX Therapeutics Inc (XRTX) Income Statement

Compare
80 Followers

XORTX Therapeutics Inc Income Statement

Last quarter (Q4 2025), XORTX Therapeutics Inc's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, XORTX Therapeutics Inc's net income was C$-823.32K. See XORTX Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Mar 23Mar 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -156.66KC$ -160.66K-C$ -75.27KC$ -17.88K
Operating Expenses
C$ 4.39MC$ 5.48MC$ 4.81MC$ 9.86MC$ 2.90M
Depreciation and Amortization
C$ 156.66KC$ 160.66KC$ 188.54KC$ 75.27KC$ 17.88K
EBITDA
C$ -4.39MC$ -4.38M-C$ -9.41M-
Operating Income
C$ -4.55MC$ -5.64M-C$ -12.43M-
Other Income/Expenses
C$ 837.97KC$ 1.10MC$ 1.95MC$ 2.95MC$ 1.25M
Pretax Income
C$ -3.71MC$ -4.54M-C$ -9.49MC$ -1.65M
Net Income
C$ -3.71MC$ -4.54M--C$ -1.65M
Per Share Metrics
Basic EPS
C$ -0.78C$ -1.58C$ -1.44C$ -4.72C$ -1.20
Diluted EPS
C$ -0.78C$ -1.58C$ -1.44C$ -4.72C$ -1.20
Weighted Average Shares Outstanding
4.73M 2.88M 1.98M 1.48M 1.09M
Weighted Average Shares Outstanding (Diluted)
4.73M 2.88M 1.98M 1.48M 1.09M
Currency in CAD

XORTX Therapeutics Inc Earnings and Revenue History